Acquisition Announced
Curium US Holdings acquisition of Lantheus Holdings
US$8bn equity value
Announced 3 Aug 2026 · NASDAQ: LNTH · US$102.50 cash per share · 38% premium
Advisers
Lantheus Holdings
Target
- Financial adviser
- Legal adviser
- Fairness opinion
Curium US Holdings
Acquirer
- Financial adviser
- Legal adviser
- Target
- Lantheus Holdings
- Acquirer
- Curium US Holdings
- Target based in
- United States
- Buyer based in
- United States
- Sector
- Radiopharmaceuticals
- Tags
- Radiopharmaceuticals, Diagnostics, Pharma
In the league tables
- M&A financial advisers, 2026 to date J.P. Morgan #1 · BofA Securities #3 · Morgan Stanley #6 · Jefferies #14 · PJT Partners #16 · Solomon Partners #29
- M&A legal advisers, 2026 to date Kirkland & Ellis #1 · Covington & Burling #10 · Ropes & Gray #25 · Arnold & Porter #36
- Fairness opinion providers, 2026 to date Morgan Stanley #3
Similar deals
- SHINE Technologies acquisition of Lantheus SPECT business Jan 2026 · Pharma
- Danaher acquisition of Masimo Feb 2026 · US$9.9bn · Medtech
- Vertex Pharmaceuticals acquisition of Crinetics Pharmaceuticals Jul 2026 · US$10bn · Biotech
- Eli Lilly and Company acquisition of Centessa Pharmaceuticals Mar 2026 · US$6.3bn · Biotech
- Biogen acquisition of Apellis Pharmaceuticals Mar 2026 · US$5.6bn · Biotech
Sources
- Jul 2026 Kirkland Advises Curium on Merger with Lantheus kirkland.com
- 3 Aug 2026 Press release (EX-99.1, exhibit), Curium Announces Definitive Agreement to Merge with Lantheus sec.gov
- 8 Sep 2026 Definitive merger proxy statement (DEFM14A), Lantheus Holdings, Inc. sec.gov






